Council for Scientific and Industrial Research (CSIR)

FILE PHOTO: Scientist Linqi Zhang shows a tube with a solution containing COVID-19 antibodies in his lab where he works on research into novel coronavirus disease (COVID-19) antibodies for possible use in a drug at Tsinghua University in Beijing

CSIR Institute Gets Nod for Conducting Clinical Trials of Antiviral Drug Umifenovir

The drug has a good safety profile and acts...